Cargando…

Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development

Since late 2019 the newly emerged pandemic SARS-CoV-2, the causative agent of COVID-19, has hit the world with recurring waves of infections necessitating the global implementation of non-pharmaceutical interventions, including strict social distancing rules, the wearing of masks and the isolation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540924/ https://www.ncbi.nlm.nih.gov/pubmed/34696160 http://dx.doi.org/10.3390/vaccines9101052

Ejemplares similares

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
por: Schloer, Sebastian, et al.
Publicado: (2021)

Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
por: Brunotte, Linda, et al.
Publicado: (2021)

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
por: Schloer, Sebastian, et al.
Publicado: (2020)

SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids
por: Menuchin-Lasowski, Yotam, et al.
Publicado: (2022)

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
por: Schreiber, André, et al.
Publicado: (2022)

Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
por: Faist, Aileen, et al.
Publicado: (2022)

Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells
por: Krischuns, Tim, et al.
Publicado: (2018)

Emerging SARS-CoV-2 variants: shooting the messenger
por: The Lancet Infectious Diseases
Publicado: (2022)

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
por: Faist, Aileen, et al.
Publicado: (2023)

The ubiquitination landscape of the influenza A virus polymerase
por: Günl, Franziska, et al.
Publicado: (2023)

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
por: Chaudhry, M. Zeeshan, et al.
Publicado: (2022)

Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA
por: Kleinehr, Jens, et al.
Publicado: (2023)

The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo
por: Schloer, Sebastian, et al.
Publicado: (2019)

3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases
por: Schloer, Sebastian, et al.
Publicado: (2022)

Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly
por: Mecate-Zambrano, Angeles, et al.
Publicado: (2020)

Plant gene silencing signals move from the phloem to influence gene expression in shoot apical meristems
por: Minow, Mark A. A., et al.
Publicado: (2022)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

Performance of T-Track(®) SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells
por: Kanis, Franziska M., et al.
Publicado: (2023)

The Field’s mass shooting: emergency medical services response
por: Hansen, Peter Martin, et al.
Publicado: (2023)

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
por: Hönzke, Katja, et al.
Publicado: (2022)

Moving on with challenges & new initiatives
por: Sharma, Anju
Publicado: (2012)

Gaucher disease and SARS-CoV-2 infection: Emerging management challenges
por: Mistry, Pramod, et al.
Publicado: (2020)

SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments
por: Adesokan, Adedapo, et al.
Publicado: (2022)

Determination of cut-off points for the Move4 accelerometer in children aged 8–13 years
por: Beck, Franziska, et al.
Publicado: (2023)

Myeloma research on the move
por: Ludwig, Heinz
Publicado: (2021)

Shooting at Moving and Hidden Targets—Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas
por: Kałafut, Joanna, et al.
Publicado: (2021)

Airborne spread of infectious SARS-CoV-2: Moving forward using lessons from SARS-CoV and MERS-CoV
por: da Silva, Priscilla Gomes, et al.
Publicado: (2021)

On the use of simulation in robotics: Opportunities, challenges, and suggestions for moving forward
por: Choi, HeeSun, et al.
Publicado: (2021)

Battle against the pandemic: Emergence of SARS-CoV2 variants and global challenge
por: Kumar, Saurabh, et al.
Publicado: (2021)

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
por: Dhama, Kuldeep, et al.
Publicado: (2023)

AXY3 encodes a α-xylosidase that impacts the structure and accessibility of the hemicellulose xyloglucan in Arabidopsis plant cell walls
por: Günl, Markus, et al.
Publicado: (2010)

Ready to shoot
Publicado: (1970)

Write to Shoot
por: Beker, Marilyn
Publicado: (2017)

Shooting Stars
Publicado: (1883)

511. Treatment with Molnupiravir in the MOVe-In and MOVe-Out Clinical Trials Results in an Increase in Transition Mutations Across the SARS-CoV-2 Genome
por: Strizki, Julie, et al.
Publicado: (2021)

SARS: The challenge of emerging pathogens to the intensivist
por: Brun-Buisson, Christian
Publicado: (2003)

Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes
por: Schreiber, André, et al.
Publicado: (2020)

Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics
por: Kumar, Sriram, et al.
Publicado: (2021)

Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World
por: Gao, Lin, et al.
Publicado: (2021)

Monitoring COVID‐19 through SARS‐CoV‐2 quantification in wastewater: progress, challenges and prospects
por: Alhama, José, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0qqtpb94bhprf01ui8ha1s7df